Dow Survives Late Selling to Eke Out Third Weekly Gain By

© Reuters.

By Yasin Ebrahim – The Dow eked out a third straight weekly win Friday, despite selling into the close as investors weighed up stronger retail sales data that pointed to underlying strength in the U.S. consumer against cooling hopes for a quick roll out of stimulus. 

The rose 0.39%, or 112 points. The was down 0.08%, while the fell 0.36%.

The Commerce Department said Friday that retail sales rose . That confounded economists’ forecast for a 0.5% rise. The retail sales control group – which has a larger impact on U.S. GDP –  , topping expectations for a 0.2% increase. 

Some economists, however, warned the data could represent the “last hurrah” for the consumer heading toward the end of the year as income will likely decline amid a lack of stimulus.  

“September strength may have been the last hurrah for the consumer this year. With the back to school/work spending likely behind us, and disposable income set to contract sharply in Q3/Q4 without fresh fiscal stimulus, we’ll be lucky if consumption is flat in Q4,” Jefferies (NYSE:) said in a note.

Despite little progress on stimulus talks, many believe that it is a matter of when rather than if further federal aid is coming, with House Speaker Nancy Pelosi suggesting earlier this week that a fiscal package will be rolled out before January.

Utilities, industrials, and health care led the broader market higher, with the latter getting a boost from a rise in shares of Regeneron Pharmaceuticals (NASDAQ:) and Pfizer .

Pfizer (NYSE:) said it would apply for emergency U.S. approval of its Covid-19 vaccine it is developing with Germany’s BioNTech in the third week of November. Pfizer and Biontech Se (NASDAQ:) both added nearly 4%.

The news helped restore some optimism over a Covid-19 vaccine after both Eli Lilly and Company (NYSE:) and Johnson & Johnson (NYSE:) announced setbacks earlier this week.

Tech, however, lagged the broader move higher even as the Fab 5 stocks closed mostly in the red, despite trading higher intraday. (NASDAQ:), Facebook (NASDAQ:), Microsoft  (NASDAQ:) and Apple (NASDAQ:) closed lower, while Google-parent Alphabet (NASDAQ:) ended the day above the flatline.

On the earnings front, investors digested mixed results from corporates.

Bank of New York Mellon (NYSE:) reported better-than-expected quarterly results on the top and bottom lines, sending its shares up 2%.

Schlumberger NV (NYSE:) fell 9% after it reported mixed results after its quarterly earnings beat, but revenue fell short of estimates, pressured by coronavirus-led disruptions in its drilling business.

In other news, Boeing (NYSE:) climbed 2% after Europe’s aviation regulator said the company’s maligned 737 Max jet was airworthy again.

In deal news, First Citizens BancShares (NASDAQ:) said it had agreed a deal to buy CIT Group Inc (NYSE:) to form a new bank with more than $100 billion assets. 

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.